Cite
Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes.
MLA
Zeidan, Amer M., et al. “Comparative Clinical Effectiveness of Azacitidine versus Decitabine in Older Patients with Myelodysplastic Syndromes.” British Journal of Haematology, vol. 175, no. 5, Dec. 2016, pp. 829–40. EBSCOhost, https://doi.org/10.1111/bjh.14305.
APA
Zeidan, A. M., Davidoff, A. J., Long, J. B., Hu, X., Wang, R., Ma, X., Gross, C. P., Abel, G. A., Huntington, S. F., Podoltsev, N. A., Hajime, U., Prebet, T., & Gore, S. D. (2016). Comparative clinical effectiveness of azacitidine versus decitabine in older patients with myelodysplastic syndromes. British Journal of Haematology, 175(5), 829–840. https://doi.org/10.1111/bjh.14305
Chicago
Zeidan, Amer M., Amy J. Davidoff, Jessica B. Long, Xin Hu, Rong Wang, Xiaomei Ma, Cary P. Gross, et al. 2016. “Comparative Clinical Effectiveness of Azacitidine versus Decitabine in Older Patients with Myelodysplastic Syndromes.” British Journal of Haematology 175 (5): 829–40. doi:10.1111/bjh.14305.